Impaired function of circulating CD34+ CD45- cells in patients with proliferative diabetic retinopathy

Experimental Eye Research

Volumn 91, Issue 2, 2010, Pages 229-237

  Tan, Kevin ^a   Lessieur, Emma ^a   Cutler, Alecia ^a   Nerone, Patrice ^a   Vasanji, Amit ^a   Asosingh, Kewal ^a   Erzurum, Serpil ^a   Anand Apte, Bela ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelial progenitor cells; Neovascularization; Retina

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIUM; CELL COUNT; CELL MIGRATION; CIRCULATION; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETINA CELL; STEM CELL; TISSUE REPAIR;

ANTIGENS, CD34; ANTIGENS, CD45; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 77954959369     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.05.012     Document Type: Article

References (46)

1. Abu El-Asrar A.M., Struyf S., Kangave D., Geboes K., Van Damme J. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Eur. Cytokine Netw. 2006, 17:155-165.
2. Alessandri G., Girelli M., Taccagni G., Colombo A., Nicosia R., Caruso A., Baronio M., Pagano S., Cova L., Parati E. Human vasculogenesis ex vivo: embryonal aorta as a tool for isolation of endothelial cell progenitors. Lab. Invest. 2001, 81:875-885.
3. Anand-Apte B., Pepper M.S., Voest E., Montesano R., Olsen B., Murphy G., Apte S.S., Zetter B. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest. Ophthalmol. Vis. Sci. 1997, 38:817-823.
4. Arjamaa O., Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 2006, 83:473-483.
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
6. + cell subsets in patients with coronary endothelial dysfunction. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:489-496.
7. Brooks H.L., Caballero S., Newell C.K., Steinmetz R.L., Watson D., Segal M.S., Harrison J.K., Scott E.W., Grant M.B. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch. Ophthalmol. 2004, 122:1801-1807.
8. Butler J.M., Guthrie S.M., Koc M., Afzal A., Caballero S., Brooks H.L., Mames R.N., Segal M.S., Grant M.B., Scott E.W. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 2005, 115:86-93.
9. Caballero S., Sengupta N., Afzal A., Chang K.H., Li Calzi S., Guberski D.L., Kern T.S., Grant M.B. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007, 56:960-967.
10. Fadini G.P. An underlying principle for the study of circulating progenitor cells in diabetes and its complications. Diabetologia 2008, 51:1091-1094.
11. Fadini G.P., Agostini C., Avogaro A. Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. Curr. Diabetes Rev. 2005, 1:41-58.
12. Fadini G.P., Sartore S., Agostini C., Avogaro A. Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 2007, 30:1305-1313.
13. Fadini G.P., Sartore S., Albiero M., Baesso I., Murphy E., Menegolo M., Grego F., Vigili de Kreutzenberg S., Tiengo A., Agostini C., Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2140-2146.
14. Fadini G.P., Sartore S., Baesso I., Lenzi M., Agostini C., Tiengo A., Avogaro A. Endothelial progenitor cells and the diabetic paradox. Diabetes Care 2006, 29:714-716.
15. Fadini G.P., Sartore S., Schiavon M., Albiero M., Baesso I., Cabrelle A., Agostini C., Avogaro A. Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 2006, 49:3075-3084.
16. Funatsu H., Yamashita H., Shimizu E., Kojima R., Hori S. Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy. Retina 2001, 21:469-477.
17. Grant M.B., Caballero S., Brown G.A., Guthrie S.M., Mames R.N., Vaught T., Scott E.W. The contribution of adult hematopoietic stem cells to retinal neovascularization. Adv. Exp. Med. Biol. 2003, 522:37-45.
18. Grant M.B., May W.S., Caballero S., Brown G.A., Guthrie S.M., Mames R.N., Byrne B.J., Vaught T., Spoerri P.E., Peck A.B., Scott E.W. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002, 8:607-612.
19. Group T.D.C.a.C.T.R. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
20. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
21. Ii M., Takenaka H., Asai J., Ibusuki K., Mizukami Y., Maruyama K., Yoon Y.S., Wecker A., Luedemann C., Eaton E., Silver M., Thorne T., Losordo D.W. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ. Res. 2006, 98:697-704.
22. Ingram D.A., Caplice N.M., Yoder M.C. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005, 106:1525-1531.
23. Ingram D.A., Mead L.E., Moore D.B., Woodard W., Fenoglio A., Yoder M.C. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005, 105:2783-2786.
24. Ingram D.A., Mead L.E., Tanaka H., Meade V., Fenoglio A., Mortell K., Pollok K., Ferkowicz M.J., Gilley D., Yoder M.C. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760.
25. Lee I.G., Chae S.L., Kim J.C. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye (Lond.) 2006, 20:546-552.
26. Liu X., Li Y., Liu Y., Luo Y., Wang D., Annex B.H., Goldschmidt-Clermont P.J. Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am. J. Pathol. 2010, 176:504-515.
27. Loomans C.J., De Koning E.J., Staal F.J., Rabelink T.J., Zonneveld A.J. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?. Antioxid. Redox Signal. 2005, 7:1468-1475.
28. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., Verhaar M.C., Braam B., Rabelink T.J., van Zonneveld A.J. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53:195-199.
29. Otani A., Kinder K., Ewalt K., Otero F.J., Schimmel P., Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 2002, 8:1004-1010.
30. Pe'er J., Folberg R., Itin A., Gnessin H., Hemo I., Keshet E. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br. J. Ophthalmol. 1996, 80:241-245.
31. Qi J.H., Ebrahem Q., Moore N., Murphy G., Claesson-Welsh L., Bond M., Baker A., Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 2003, 9:407-415.
32. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
33. Shao H., Tan Y., Eton D., Yang Z., Uberti M.G., Li S., Schulick A., Yu H. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells 2008, 26:1376-1384.
34. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., Hammond W.P. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
35. Smadja D.M., Bieche I., Helley D., Laurendeau I., Simonin G., Muller L., Aiach M., Gaussem P. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha (6). J. Cell. Mol. Med. 2007, 11:1149-1161.
36. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., Hadden D., Turner R.C., Holman R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405-412.
37. Suzuma K., Takagi H., Otani A., Oh H., Honda Y. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. Am. J. Pathol. 1999, 154:343-354.
38. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
39. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., Gurtner G.C. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106:2781-2786.
40. Thill M., Strunnikova N.V., Berna M.J., Gordiyenko N., Schmid K., Cousins S.W., Thompson D.J., Csaky K.G. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:2696-2708.
41. Watanabe D., Suzuma K., Matsui S., Kurimoto M., Kiryu J., Kita M., Suzuma I., Ohashi H., Ojima T., Murakami T., Kobayashi T., Masuda S., Nagao M., Yoshimura N., Takagi H. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 2005, 353:782-792.
42. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch-Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
43. Yoder M.C. Defining human endothelial progenitor cells. J. Thromb. Haemost. 2009, 7(Suppl. 1):49-52.
44. Yoder M.C., Ingram D.A. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr. Opin. Hematol. 2009, 16:269-273.
45. Yoder M.C., Ingram D.A. The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?. Biochim. Biophys. Acta 2009, 1796:50-54.
46. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.